BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Solmi M, Veronese N, Thapa N, Facchini S, Stubbs B, Fornaro M, Carvalho AF, Correll CU. Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia. CNS Spectr 2017;22:415-26. [PMID: 28181901 DOI: 10.1017/S1092852916000638] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 7.6] [Reference Citation Analysis]
Number Citing Articles
1 Ortinski PI, Reissner KJ, Turner J, Anderson TA, Scimemi A. Control of complex behavior by astrocytes and microglia. Neurosci Biobehav Rev 2022;137:104651. [PMID: 35367512 DOI: 10.1016/j.neubiorev.2022.104651] [Reference Citation Analysis]
2 Wegrzyn D, Juckel G, Faissner A. Structural and Functional Deviations of the Hippocampus in Schizophrenia and Schizophrenia Animal Models. Int J Mol Sci 2022;23:5482. [PMID: 35628292 DOI: 10.3390/ijms23105482] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Westacott LJ, Wilkinson LS. Complement Dependent Synaptic Reorganisation During Critical Periods of Brain Development and Risk for Psychiatric Disorder. Front Neurosci 2022;16:840266. [DOI: 10.3389/fnins.2022.840266] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Upmark F, Sjöqvist H, Hayes JF, Dalman C, Karlsson H. Doxycycline exposure during adolescence and future risk of non-affective psychosis and bipolar disorder: a total population cohort study. Transl Psychiatry 2021;11:468. [PMID: 34497261 DOI: 10.1038/s41398-021-01574-6] [Reference Citation Analysis]
5 Seitz-Holland J, Seethaler M, Makris N, Rushmore J, Cho KK, Rizzoni E, Vangel M, Sahin OS, Heller C, Pasternak O, Szczepankiewicz F, Westin CF, Lošák J, Ustohal L, Tomandl J, Vojtíšek L, Kudlička P, Jáni M, Woo TW, Kašpárek T, Kikinis Z, Kubicki M. The association of matrix metalloproteinase 9 (MMP9) with hippocampal volume in schizophrenia: a preliminary MRI study. Neuropsychopharmacology 2021. [PMID: 33833403 DOI: 10.1038/s41386-021-00997-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Galderisi S, Kaiser S, Bitter I, Nordentoft M, Mucci A, Sabé M, Giordano GM, Nielsen MØ, Glenthøj LB, Pezzella P, Falkai P, Dollfus S, Gaebel W. EPA guidance on treatment of negative symptoms in schizophrenia. Eur Psychiatry 2021;64:e21. [PMID: 33726883 DOI: 10.1192/j.eurpsy.2021.13] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 24.0] [Reference Citation Analysis]
7 Sanches M, Quevedo J, Soares JC. New agents and perspectives in the pharmacological treatment of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2021;106:110157. [PMID: 33159975 DOI: 10.1016/j.pnpbp.2020.110157] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
8 Ouabbou S, He Y, Butler K, Tsuang M. Inflammation in Mental Disorders: Is the Microbiota the Missing Link? Neurosci Bull 2020;36:1071-84. [PMID: 32592144 DOI: 10.1007/s12264-020-00535-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 Xu C, Sellgren CM, Fatouros-Bergman H, Piehl F, Blennow K, Zetterberg H, Brinkmalm A, Santillo AF, Lundgren S, Cervenka S, Engberg G, Erhardt S; Karolinska Schizophrenia Project (KaSP) Consortium. CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects. IBRO Rep 2020;8:136-42. [PMID: 32490278 DOI: 10.1016/j.ibror.2020.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Bortolasci CC, Marx W, Walker AJ, Hasebe K, Kavanagh BE, Morris MJ, Mohebbi M, Turner A, Gray L, Berk L, Walder K, Berk M, Dean OM. Minocycline for the treatment of mental health and neurological conditions: study protocol of a systematic review and meta-analysis. BMJ Open 2020;10:e035080. [PMID: 32198305 DOI: 10.1136/bmjopen-2019-035080] [Reference Citation Analysis]
11 Wang XS, Shi Q, Mendoza T, Lin S, Chang JY, Bokhari RH, Lin HK, Garcia-Gonzalez A, Kamal M, Cleeland CS, Liao Z. Minocycline Reduces Chemoradiation-Related Symptom Burden in Patients with Non-Small Cell Lung Cancer: A Phase 2 Randomized Trial. Int J Radiat Oncol Biol Phys 2020;106:100-7. [PMID: 31627177 DOI: 10.1016/j.ijrobp.2019.10.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
12 May M, Beauchemin M, Vary C, Barlow D, Houseknecht KL. The antipsychotic medication, risperidone, causes global immunosuppression in healthy mice. PLoS One 2019;14:e0218937. [PMID: 31242264 DOI: 10.1371/journal.pone.0218937] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
13 Rogers JP, Pollak TA, Blackman G, David AS. Catatonia and the immune system: a review. Lancet Psychiatry 2019;6:620-30. [PMID: 31196793 DOI: 10.1016/S2215-0366(19)30190-7] [Cited by in Crossref: 73] [Cited by in F6Publishing: 61] [Article Influence: 24.3] [Reference Citation Analysis]
14 Koola MM, Praharaj SK, Pillai A. Galantamine-Memantine Combination as an Antioxidant Treatment for Schizophrenia. Curr Behav Neurosci Rep 2019;6:37-50. [PMID: 32601581 DOI: 10.1007/s40473-019-00174-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
15 Sellgren CM, Gracias J, Watmuff B, Biag JD, Thanos JM, Whittredge PB, Fu T, Worringer K, Brown HE, Wang J, Kaykas A, Karmacharya R, Goold CP, Sheridan SD, Perlis RH. Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning. Nat Neurosci 2019;22:374-85. [PMID: 30718903 DOI: 10.1038/s41593-018-0334-7] [Cited by in Crossref: 201] [Cited by in F6Publishing: 242] [Article Influence: 67.0] [Reference Citation Analysis]
16 Kroken RA, Sommer IE, Steen VM, Dieset I, Johnsen E. Constructing the Immune Signature of Schizophrenia for Clinical Use and Research; An Integrative Review Translating Descriptives Into Diagnostics. Front Psychiatry. 2018;9:753. [PMID: 30766494 DOI: 10.3389/fpsyt.2018.00753] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 9.3] [Reference Citation Analysis]
17 Perez-Gomez A, Carretero M, Weber N, Peterka V, To A, Titova V, Solis G, Osborn O, Petrascheck M. A phenotypic Caenorhabditis elegans screen identifies a selective suppressor of antipsychotic-induced hyperphagia. Nat Commun 2018;9:5272. [PMID: 30532051 DOI: 10.1038/s41467-018-07684-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
18 Tufvesson-Alm M, Schwieler L, Schwarcz R, Goiny M, Erhardt S, Engberg G. Importance of kynurenine 3-monooxygenase for spontaneous firing and pharmacological responses of midbrain dopamine neurons: Relevance for schizophrenia. Neuropharmacology 2018;138:130-9. [PMID: 29879409 DOI: 10.1016/j.neuropharm.2018.06.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
19 Severance EG, Dickerson FB, Yolken RH. Autoimmune phenotypes in schizophrenia reveal novel treatment targets. Pharmacol Ther. 2018;189:184-198. [PMID: 29742478 DOI: 10.1016/j.pharmthera.2018.05.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
20 Firth J, Rosenbaum S, Ward PB, Curtis J, Teasdale SB, Yung AR, Sarris J. Adjunctive nutrients in first-episode psychosis: A systematic review of efficacy, tolerability and neurobiological mechanisms. Early Interv Psychiatry 2018;12:774-83. [PMID: 29561067 DOI: 10.1111/eip.12544] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
21 Osimo EF, Cardinal RN, Jones PB, Khandaker GM. Prevalence and correlates of low-grade systemic inflammation in adult psychiatric inpatients: An electronic health record-based study. Psychoneuroendocrinology. 2018;91:226-234. [PMID: 29544672 DOI: 10.1016/j.psyneuen.2018.02.031] [Cited by in Crossref: 37] [Cited by in F6Publishing: 46] [Article Influence: 9.3] [Reference Citation Analysis]
22 Morrison PD, Murray RM. The antipsychotic landscape: dopamine and beyond. Ther Adv Psychopharmacol 2018;8:127-35. [PMID: 29607005 DOI: 10.1177/2045125317752915] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
23 De Picker LJ, Morrens M, Chance SA, Boche D. Microglia and Brain Plasticity in Acute Psychosis and Schizophrenia Illness Course: A Meta-Review. Front Psychiatry 2017;8:238. [PMID: 29201010 DOI: 10.3389/fpsyt.2017.00238] [Cited by in Crossref: 64] [Cited by in F6Publishing: 69] [Article Influence: 12.8] [Reference Citation Analysis]
24 Correll CU, Rubio JM, Inczedy-Farkas G, Birnbaum ML, Kane JM, Leucht S. Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia: Systematic Overview and Quality Appraisal of the Meta-analytic Evidence. JAMA Psychiatry. 2017;74:675-684. [PMID: 28514486 DOI: 10.1001/jamapsychiatry.2017.0624] [Cited by in Crossref: 83] [Cited by in F6Publishing: 77] [Article Influence: 16.6] [Reference Citation Analysis]